The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients

Background: End stage renal disease (ESRD) is a condition that inflammation and oxidative stress plays an important role in damaging to tissues, especially, in the vascular system. The effect of omega-3 fatty acids is well-documented in some inflammatory diseases via eicosapentanoic acid and docosah...

Full description

Bibliographic Details
Main Authors: Shahram Taheri, Nooshin Keyvandarian, Firouzeh Moeinzadeh, Mojgan Mortazavi, Afsoon Emami Naini
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Advanced Biomedical Research
Subjects:
Online Access:http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=143;epage=143;aulast=Taheri
_version_ 1830285798959742976
author Shahram Taheri
Nooshin Keyvandarian
Firouzeh Moeinzadeh
Mojgan Mortazavi
Afsoon Emami Naini
author_facet Shahram Taheri
Nooshin Keyvandarian
Firouzeh Moeinzadeh
Mojgan Mortazavi
Afsoon Emami Naini
author_sort Shahram Taheri
collection DOAJ
description Background: End stage renal disease (ESRD) is a condition that inflammation and oxidative stress plays an important role in damaging to tissues, especially, in the vascular system. The effect of omega-3 fatty acids is well-documented in some inflammatory diseases via eicosapentanoic acid and docosahexanoic acid components of fish oil. The aim of this study was to investigate the effects of dietary omega-3 fatty acid supplementation on levels of lipid peroxidation and oxidative sttress in ESRD patients. Materials and Methods: This randomized controlled double-blind clinical trial consisted of 90 patients on chronic ambulatory peritoneal dialysis (CAPD). One group was treated orally with 3000 mg omega-3, per day for 8 weeks (n = 45) and the other matched group by placebo (n = 45). Serum levels of lipids, iron, ferritin, Protrombin Time, Partial thromboplastin time, superoxide dismutase (SOD), and reduced glutathione (GH) were measured at the beginning and at 8 weeks. Results: Our results showed that SOD and reduced GH were not significantly changed in omega-3 group where lipid profile showed no significant changes too. Erythropoietin requirements also had no significant differences. Conclusion: Incorporation of omega-3 fatty acids to CAPD patients had no beneficial effects on oxidative stress but should evaluate more.
first_indexed 2024-12-19T03:46:06Z
format Article
id doaj.art-919a6cb120504c159fa3b1273b8d253d
institution Directory Open Access Journal
issn 2277-9175
2277-9175
language English
last_indexed 2024-12-19T03:46:06Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Advanced Biomedical Research
spelling doaj.art-919a6cb120504c159fa3b1273b8d253d2022-12-21T20:37:06ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752277-91752014-01-013114314310.4103/2277-9175.135160The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patientsShahram TaheriNooshin KeyvandarianFirouzeh MoeinzadehMojgan MortazaviAfsoon Emami NainiBackground: End stage renal disease (ESRD) is a condition that inflammation and oxidative stress plays an important role in damaging to tissues, especially, in the vascular system. The effect of omega-3 fatty acids is well-documented in some inflammatory diseases via eicosapentanoic acid and docosahexanoic acid components of fish oil. The aim of this study was to investigate the effects of dietary omega-3 fatty acid supplementation on levels of lipid peroxidation and oxidative sttress in ESRD patients. Materials and Methods: This randomized controlled double-blind clinical trial consisted of 90 patients on chronic ambulatory peritoneal dialysis (CAPD). One group was treated orally with 3000 mg omega-3, per day for 8 weeks (n = 45) and the other matched group by placebo (n = 45). Serum levels of lipids, iron, ferritin, Protrombin Time, Partial thromboplastin time, superoxide dismutase (SOD), and reduced glutathione (GH) were measured at the beginning and at 8 weeks. Results: Our results showed that SOD and reduced GH were not significantly changed in omega-3 group where lipid profile showed no significant changes too. Erythropoietin requirements also had no significant differences. Conclusion: Incorporation of omega-3 fatty acids to CAPD patients had no beneficial effects on oxidative stress but should evaluate more.http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=143;epage=143;aulast=TaheriChronic ambulatory peritoneal dialysisomega-3 fatty acidsoxidative stressreduced glutathionesuperoxide dismutase
spellingShingle Shahram Taheri
Nooshin Keyvandarian
Firouzeh Moeinzadeh
Mojgan Mortazavi
Afsoon Emami Naini
The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
Advanced Biomedical Research
Chronic ambulatory peritoneal dialysis
omega-3 fatty acids
oxidative stress
reduced glutathione
superoxide dismutase
title The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
title_full The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
title_fullStr The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
title_full_unstemmed The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
title_short The effect of omega-3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
title_sort effect of omega 3 fatty acid supplementation on oxidative stress in continuous ambulatory peritoneal dialysis patients
topic Chronic ambulatory peritoneal dialysis
omega-3 fatty acids
oxidative stress
reduced glutathione
superoxide dismutase
url http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=143;epage=143;aulast=Taheri
work_keys_str_mv AT shahramtaheri theeffectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT nooshinkeyvandarian theeffectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT firouzehmoeinzadeh theeffectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT mojganmortazavi theeffectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT afsoonemaminaini theeffectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT shahramtaheri effectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT nooshinkeyvandarian effectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT firouzehmoeinzadeh effectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT mojganmortazavi effectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients
AT afsoonemaminaini effectofomega3fattyacidsupplementationonoxidativestressincontinuousambulatoryperitonealdialysispatients